JENNY YEE-LEVIN: Open Payments
NPI 1902922586 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,189 in 42 payments from 13 companies in 2025. Trend: 2023 $704 · 2024 $667 · 2025 $1,189
Food & beverage: $1,189
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $405 |
| AstraZeneca Pharmaceuticals LP | 9 | $266 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Optinose US, Inc. | 3 | $59 |
| Amgen Inc. | 2 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Exact Sciences Corporation | 1 | $33 |
| CSL Behring | 1 | $32 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, Xhance, NUCALA, VOQUEZNA, NUZYRA, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
